Story
Sleep supplements, sorted by where they act
Falling asleep is driven by sleep pressure, the body clock, and stress, and each sleep supplement touches only one of them, mostly with evidence from small trials. The first choice for chronic insomnia is still cognitive behavioral therapy.
Last updated
Overview and key questions
In short: Each sleep supplement touches only one link in the control of sleep, so first work out which link your poor sleep is stuck on, then see which ingredient lands on that link.
Educational content, not medical advice. See a clinician about your own case.
Story path
Chapter 1
The forces that push you into sleep
Sleepiness comes from two forces. One is sleep pressure: the longer you stay awake, the sleepier you get, and only sleep clears it. The other is the body clock: running on a roughly one-day rhythm, it decides what time you should feel sleepy.
Both forces end up pushing on a switch. In the preoptic area of the hypothalamus, a group of sleep-promoting neurons releases gamma-aminobutyric acid (, an inhibitory signal) and holds down the brain regions that keep you awake. Stress is another force that can push this switch, and it often keeps the wake side switched on.
On this map, melatonin sits on the body clock, glycine on the cool-down before sleep, theanine and magnesium are often said to act on the GABA brake, and ashwagandha sits on stress. None of the common sleep supplements adds sleep pressure directly. The first-line treatment for chronic insomnia is cognitive behavioral therapy for insomnia (), and its sleep-restriction component is designed to strengthen exactly this pressure. If you are sleeping badly and have thoughts of harming yourself, go to an emergency department now or call 120.
Mechanism · How the sleep-wake switch flips
The two sides suppress each other. When the sleep side gains the upper hand, it presses the wake side down further, and the reverse is also true. One review argues that this mutual suppression is what makes the switch from waking to sleep, and from sleep to waking, relatively fast and complete, instead of leaving you stuck in a long half-asleep state.
Three kinds of drive push on the switch.
The homeostatic drive is sleep pressure. While you are awake, by-products of metabolism such as adenosine may slowly build up outside cells in the brain; but the review also states that adenosine alone is unlikely to explain all of sleep pressure. Caffeine keeps you awake because it blocks adenosine's receptors, which is established pharmacology in people; which receptor type does the work comes from experiments in mice.
The circadian drive comes from the master clock, the suprachiasmatic nucleus. The clock itself has very little direct connection to the sleep-wake switch. Sleep pressure and the body clock interact with each other continuously.
The allostatic drive is where stress belongs, and behavioral stress often causes insomnia. In rat experiments, stress activates neurons on both the sleep-promoting and the wake-promoting side at the same time. The review suggests that stress-related insomnia may be a state in which neither side can overpower the other.
That is why sleep supplements should be judged link by link: trouble sleeping that is stuck on stress and trouble sleeping that is stuck on timing are two different problems.
Evidence · What two guidelines say on sleep aids
The American Academy of Sleep Medicine (AASM) 2017 guideline on drug treatment suggests that clinicians not use melatonin, tryptophan or valerian to treat trouble falling asleep or staying asleep in chronic insomnia, and all three are weak recommendations. The guideline itself explains what weak means: it reflects lower certainty about the outcome and should not be read as proof that a treatment does not work.
The reasons differ for each of the three:
Melatonin: three trials in older adults; on , people fell asleep only 8.9 minutes sooner, below the threshold of clinical significance, and the overall quality of evidence was very lowValerian: the shortening of time to fall asleep also fell short of the clinical threshold, and the quality of evidence was lowTryptophan: the trials did not collect adverse effects systematically, and the panel judged that the harms may outweigh the benefits
The 2023 European insomnia guideline recommends CBT-I as the first-line treatment for chronic insomnia in adults of any age, including people with other illnesses, delivered in person or online; only when CBT-I is not effective enough is a drug considered. It does not recommend fast-release melatonin or herbal medicines for insomnia, and allows prolonged-release melatonin for people aged 55 and over for up to 3 months.
So once insomnia has become chronic, the guidelines' first step is CBT-I. If insomnia has gone on past 3 months and is affecting your days, see a doctor and start with CBT-I (see Insomnia). If you snore loudly, wake up gasping at night and can barely stay awake by day, get checked for sleep apnea first. If low mood will not lift, see a doctor too; if you have thoughts of harming yourself, go to an emergency department now or call 120.
Chapter 2
Melatonin works on the body clock
One review sorts what melatonin taken by mouth can do into three things: help you fall asleep when the body's sleep pressure is not high enough; damp down the wake drive sent out by the body clock; and shift the body clock earlier or later, so that the sleepy window lands at the time you want.
Used for ordinary insomnia, its effect is small: in a that pooled 17 studies, it brought sleep forward by only about 4 minutes on average.
If you take the antidepressant fluvoxamine, do not add melatonin on your own; ask the prescribing doctor first. In a small trial of 5 healthy men, taking the two together raised the total amount of melatonin in the blood to 17 times as much on average.
When to take it, how to use it for jet lag and shift work, and whether the amount on the label can be trusted are covered in Melatonin.
Chapter 3
Glycine and the pre-sleep cool-down
The link works like this. Before lights out, the blood vessels in the skin of the hands and feet open up and release heat from the trunk through the limbs; core temperature falls, and you grow sleepy along with it. In a laboratory study of healthy men, how widely the vessels of the hands and feet opened was the best physiological predictor of how quickly people fell asleep.
The evidence for glycine comes in two layers. When rats take it by mouth, glycine rises in the blood and in the cerebrospinal fluid, blood flow to the skin increases, and core temperature falls. In people there are only a few small trials, which found better self-rated sleep and faster sleep onset; whether glycine also works through cooling in people has not been measured directly.
A foot soak touches the same link, only by warming the hands and feet from outside; its evidence for sleep is set out in What a foot soak actually does.
Mechanism · Why cold hands and feet delay sleep
In people on a regular schedule, sleep usually begins on the downward stretch of the core body temperature curve, right when temperature is changing fastest and the body is losing the most heat. Before lights out, the blood vessels in the outer skin of the hands and feet selectively open and let the heat out, and this makes you sleepy and helps you fall asleep sooner.
The reverse case is vasospastic syndrome, a group of people whose hands and feet get cold very easily. In the research, women with it had a lower capacity to lose heat during the day, took longer to fall asleep, and had their body clock out of step with their sleep schedule.
These findings have limits worth reading carefully. The link between opening of the vessels in the hands and feet and how quickly people fell asleep is a correlation measured in healthy men in a laboratory; that study did not test foot soaks, hot baths or any other way of warming from outside. Treating trouble falling asleep by adjusting blood flow to the hands and feet is, in the author's words, a hypothesis, not a tested treatment.
In rats, glycine increased blood flow to the skin and lowered body temperature, which fits this heat-loss chain, but that step has not been measured in people.
Chapter 4
The brain's brake, thinnest evidence
The brake itself is real: at sleep onset, a group of neurons in the preoptic area of the hypothalamus releases GABA and holds down the brain regions that keep you awake.
The question is whether a supplement can reach it. No one has directly measured whether GABA taken by mouth crosses the blood-brain barrier in people, and across 14 human trials its evidence for sleep is very limited. The claim that theanine raises GABA in the brain comes from animal experiments. In three randomized trials in older adults, magnesium helped people fall asleep about 17 minutes sooner, with no difference in total sleep time, and the evidence was of low to very low quality.
So at most these three give a small boost; do not treat them as sleeping pills. If you take a prescription sleeping pill or another sedative, tell the prescribing doctor before adding any sleep supplement.
Evidence · What theanine sleep trials measured
A systematic review that pooled 9 randomized trials concluded that in people exposed to stressful situations, theanine may help reduce stress and anxiety, and that longer and larger studies are needed before it can be justified as a treatment.
One crossover trial in Japan did look at sleep directly: 30 adults without major psychiatric illness took theanine and a placebo for 4 weeks each, every night before bed. Comparing before and after theanine, scores for depression, anxiety and a sleep questionnaire all fell, but that is a before-and-after comparison that does not subtract the placebo. Compared directly with placebo, only three parts of the sleep questionnaire differed: time to fall asleep, sleep disturbance and use of sleep medication. The authors themselves note that only about one in five of the scores pulled away from placebo. Two of the authors were employed by the company that supplied the tablets.
The mechanism side also needs a careful reading. In rat neurons, theanine can bind the receptors for glutamate (an excitatory signal), but far more weakly than glutamate itself. The finding that it raises and other signaling molecules in the brain comes from neurochemistry studies in animals.
So theanine's place on the brake link is inferred from animal experiments; what has been measured in people is a small subjective improvement.
Chapter 5
Ashwagandha works on the stress link
Its human evidence is somewhat larger than for the others. In stressed adults, several randomized trials saw serum (a stress hormone) fall. A that pooled 5 randomized trials found a small but statistically significant improvement in sleep, more marked in people diagnosed with insomnia and in those who took it for 8 weeks or longer.
How it helps sleep is not clear: rat experiments point to , and a mouse experiment points to a small molecule in the water extract.
One safety point to remember: there are case reports of liver injury after taking it, and people who already had chronic liver disease fared worst, some progressing to liver failure and death, so anyone with existing liver disease should not use it. Do not use it during pregnancy or while breastfeeding, and it is not recommended for people with thyroid or autoimmune disorders. If your skin or the whites of your eyes turn yellow (jaundice) while taking it, stop and see a doctor. There are also not enough data to say whether long-term use is safe; the other cautions are covered in Ashwagandha.
Evidence · Where the ashwagandha meta-analysis stops
Only 5 randomized trials, and only 1 of them in older adultsThe trials lasted only about 8 weeks on average, so longer-term effects and safety are largely unknown1 trial declared partial funding from the manufacturer, and only 2 were registered in advance
The trials used different tools to measure sleep, and their results varied considerably. Beyond sleep itself, alertness on waking and anxiety levels also improved, while quality of life did not change noticeably.
None of the 5 trials reported serious adverse effects, but the authors state that data on serious adverse effects are limited and that more safety data are needed to judge whether long-term use is safe. Liver injury so far comes from case reports: in a series of 5 cases from Iceland and the US, all got better on their own after stopping, and in a series from India, people who already had chronic liver disease fared worst.
Chapter 6
How much human evidence ziziphus has
One randomized trial of the single herb was run in Australia: 12 people with insomnia took ziziphus granules and a placebo for 4 weeks each, one after the other. Compared with placebo, scores on a sleep-quality questionnaire were better, and the other measures did not differ; it was well tolerated, with only minor adverse effects. This was a feasibility trial, meant to test whether a larger trial could be run, and it cannot settle whether the herb works.
The larger pool of evidence is herbal formulas. One systematic review examined 217 randomized trials and found that only 8 met a standard of methodological quality; in those few, the herbal medicine did about as well as placebo and about as well as Western drugs. The authors concluded that the current evidence is not enough to support its efficacy.
The mechanism has only been traced in mice: saponins and flavonoids from the seed prolonged sleep induced by a barbiturate drug, a sedative effect that has not been confirmed in people.
Across all of these supplements, once insomnia has become chronic, the first step is still cognitive behavioral therapy for insomnia, not switching to another supplement.
References (25)
- Borbély, A. A., Daan, S., Wirz-Justice, A., & Deboer, T. (2016). The two-process model of sleep regulation: a reappraisal. Journal of Sleep Research, 25(2), 131-143. 10.1111/jsr.12371
- Saper, C. B., Fuller, P. M., Pedersen, N. P., Lu, J., & Scammell, T. E. (2010). Sleep state switching. Neuron, 68(6), 1023-1042. 10.1016/j.neuron.2010.11.032
- Riemann, D., Espie, C. A., Altena, E., Arnardottir, E. S., Baglioni, C., Bassetti, C. L. A., et al. (2023). The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023. Journal of Sleep Research, 32(6), e14035. 10.1111/jsr.14035
- Maurer, L. F., Espie, C. A., & Kyle, S. D. (2018). How does sleep restriction therapy for insomnia work? A systematic review of mechanistic evidence and the introduction of the Triple-R model. Sleep Medicine Reviews, 42, 127-138. 10.1016/j.smrv.2018.07.005
- Cajochen, C., Kräuchi, K., & Wirz-Justice, A. (2003). Role of melatonin in the regulation of human circadian rhythms and sleep. Journal of Neuroendocrinology, 15(4), 432-437. 10.1046/j.1365-2826.2003.00989.x
- Brzezinski, A., et al. (2005). Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Medicine Reviews, 9(1), 41–50. 10.1016/j.smrv.2004.06.004
- Härtter, S., Grözinger, M., Weigmann, H., Röschke, J., & Hiemke, C. (2000). Increased bioavailability of oral melatonin after fluvoxamine coadministration. Clinical Pharmacology and Therapeutics, 67(1), 1-6. 10.1067/mcp.2000.104071
- Kräuchi, K. (2007). The thermophysiological cascade leading to sleep initiation in relation to phase of entrainment. Sleep Medicine Reviews, 11(6), 439–451. 10.1016/j.smrv.2007.07.001
- Bannai, M., & Kawai, N. (2012). New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep. Journal of Pharmacological Sciences, 118(2), 145-148. 10.1254/jphs.11R04FM
- Kräuchi, K., Cajochen, C., Werth, E., & Wirz-Justice, A. (1999). Warm feet promote the rapid onset of sleep. Nature, 401(6748), 36–37. 10.1038/43366
- Yamadera, W., Inagawa, K., Chiba, S., Bannai, M., Takahashi, M., & Nakayama, K. (2007). Glycine ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes. Sleep and Biological Rhythms, 5(2), 126-131. 10.1111/j.1479-8425.2007.00262.x
- Hepsomali, P., Groeger, J. A., Nishihira, J., & Scholey, A. (2020). Effects of oral gamma-aminobutyric acid (GABA) administration on stress and sleep in humans: A systematic review. Frontiers in Neuroscience, 14, 923. 10.3389/fnins.2020.00923
- Mah, J., & Pitre, T. (2021). Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis. BMC Complementary Medicine and Therapies, 21(1), 125. 10.1186/s12906-021-03297-z
- Boonstra, E., de Kleijn, R., Colzato, L. S., Alkemade, A., Forstmann, B. U., & Nieuwenhuis, S. (2015). Neurotransmitters as food supplements: The effects of GABA on brain and behavior. Frontiers in Psychology, 6, 1520. 10.3389/fpsyg.2015.01520
- Nathan, P. J., Lu, K., Gray, M., & Oliver, C. (2006). The neuropharmacology of L-theanine (N-ethyl-L-glutamine): a possible neuroprotective and cognitive enhancing agent. Journal of Herbal Pharmacotherapy, 6(2), 21-30. 10.1080/j157v06n02_02
- Riemann, D., Spiegelhalder, K., Feige, B., Voderholzer, U., Berger, M., Perlis, M., & Nissen, C. (2010). The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Medicine Reviews, 14(1), 19-31. 10.1016/j.smrv.2009.04.002
- Chandrasekhar, K., Kapoor, J., & Anishetty, S. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of Ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine, 34(3), 255–262. 10.4103/0253-7176.106022
- Salve, J., et al. (2019). Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults: a double-blind, randomized, placebo-controlled clinical study. Cureus, 11(12), e6466. 10.7759/cureus.6466
- Cheah, K. L., Norhayati, M. N., Husniati Yaacob, L., & Abdul Rahman, R. (2021). Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis. PLoS ONE, 16(9), e0257843. 10.1371/journal.pone.0257843
- Philips, C. A., Valsan, A., et al. (2023). Ashwagandha-induced liver injury — A case series from India and literature review. Hepatology Communications, 7(10), e0270. 10.1097/HC9.0000000000000270
- Björnsson, H. K., Björnsson, E. S., Avula, B., Khan, I. A., et al. (2020). Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network. Liver International, 40(4), 825-829. pubmed.ncbi.nlm.nih.gov/31991029
- National Center for Complementary and Integrative Health. (2023). Ashwagandha (last updated March 2023). www.nccih.nih.gov/health/ashwagandha
- Yeung, W. F., Chung, K. F., Poon, M. M., Ho, F. Y., Zhang, S. P., Zhang, Z. J., Ziea, E. T., & Wong, V. T. (2012). Chinese herbal medicine for insomnia: a systematic review of randomized controlled trials. Sleep Medicine Reviews, 16(6), 497-507. 10.1016/j.smrv.2011.12.005
- Shergis, J. L., Hyde, A., Meaklim, H., Varma, P., Da Costa, C., & Jackson, M. L. (2021). Medicinal seeds Ziziphus spinosa for insomnia: A randomized, placebo-controlled, cross-over, feasibility clinical trial. Complementary Therapies in Medicine, 57, 102657. 10.1016/j.ctim.2020.102657
- Jiang, J. G., Huang, X. J., Chen, J., & Lin, Q. S. (2007). Comparison of the sedative and hypnotic effects of flavonoids, saponins, and polysaccharides extracted from Semen Ziziphus jujube. Natural Product Research, 21(4), 310-320. 10.1080/14786410701192827
Written from the sources listed above. Checked sentence by sentence against them in . No physician reviews this site: it explains how the body works, and it is not medical advice. How we make content
Spotted an error, or something unclear? Email us. We read every message, check it against the sources, and fix what's wrong.